Abiopharma

News list

Cline Christopher R. 🔴 sold 470 shares of Travere Therapeutics, Inc. (TVTX) at $17.31 Transaction Date: Aug 27, 2025 | Filing ID: 023209

Full text

News bot Aug. 28, 2025, 8:05 p.m.
🔍 Cline Christopher R. (Executive)

Company: Travere Therapeutics, Inc. (TVTX)

Report Date: 2025-08-27
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 470
Detailed Transactions and Holdings:
- Sold 470 shares of Common Stock at $17.31 per share (Direct)
  Date: 2025-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 92,656.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in May 2025.